Clinical Trial Update: [¹⁴C] Hydronidone Mass Balance Study [Phase 1]

View source ↗

Summary

Phase 1 mass balance pharmacokinetic study of [14C] Hydronidone in patients with chronic hepatitis B-related liver fibrosis; the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Liver Fibrosis

Drugs mentioned

• Hydronidone (Hydronidone)

Snippet

Sponsor: Beijing Continent Pharmaceutical Co, Ltd. | Conditions: Chronic Hepatitis B-related Liver Fibrosis | Phase 1 | Status: NOT_YET_RECRUITING